We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNVR:NASDAQHanover Bancorp, Inc. Analysis

Data as of 2026-05-20 - not real-time

$22.68

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Hanover Bancorp is trading at $22.68, just below its 20‑day SMA of $22.94 but comfortably above the 50‑day SMA of $22.14, indicating a short‑term pullback within a neutral trend. The RSI sits at 49.3, signaling no clear momentum, while the MACD histogram is negative and the signal line is bearish, suggesting further downside pressure in the near term. Support at $21.91 and resistance at $24.49 frame a modest upside potential of about 6.9% to the DCF‑derived fair value of $25.08. On the fundamentals side, the stock trades at a forward PE of 7.9 versus a trailing PE of 21.6, a price‑to‑book of 0.83 and a dividend yield of 1.75% with a 38% payout, all pointing to value characteristics and dividend sustainability. The balance sheet is strong with $194 M cash offsetting $128 M debt, and the recent $35 M private placement of subordinated notes adds liquidity. Q1 results showed net income of $1.9 M ($0.25 EPS), reinforcing modest earnings growth, while operating margins remain healthy at 29.8%. Market sentiment is highly optimistic, reflected by a Fear & Greed Index of 89 (Extreme Greed), but the 30‑day volatility of 19% and a beta of 0.66 suggest measured price swings. Overall, the stock appears undervalued relative to its DCF target and book value, yet technical indicators caution against immediate upside.
Given the blend of value metrics, sustainable dividend, and solid cash position, a medium‑ to long‑term investment case is compelling, though short‑term traders should respect the bearish MACD and proximity to support. Investors should monitor volume trends—currently increasing—and any further capital raises that could dilute equity. The regional banking sector’s regulatory environment and interest‑rate sensitivity remain medium‑level risks, but Hanover’s geographic focus in NY/NJ limits broader geographic exposure. Maintaining a watch on earnings momentum and the ability to sustain dividend payouts will be key to realizing the upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support at $21.91
  • Bearish MACD histogram indicating potential further downside
  • Neutral RSI and increasing volume suggest uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE of 7.9 versus industry trailing PE of 16.5
  • DCF fair value of $25.08 offering ~7% upside
  • Sustainable dividend yield of 1.75% with 38% payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low price‑to‑book ratio (0.83) indicating deep value
  • Strong cash position relative to debt and ongoing capital raises
  • Stable earnings growth and healthy operating margins

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin12.30%
P/E Ratio21.6
ROE3.94%
ROA0.34%
P/B Ratio0.8
Op. Cash Flow$10.3M
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI49.3
Support$21.91
Resistance$24.49
MA 20$22.94
MA 50$22.14
MA 200$22.32
MACDBearish
VolumeIncreasing
Fear & Greed Index89.18

Valuation

Fair Value$25.08
Target Price$24.25
Upside/Downside6.92%
GradeUndervalued
TypeBlend
Dividend Yield1.75%

Risk Assessment

Beta0.66
Volatility18.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.